Literature DB >> 4622116

The clinical application of adjuvant 65.

M R Hilleman, A Woodhour, A Friedman, R E Weibel, J Stokes.   

Abstract

Mesh:

Substances:

Year:  1972        PMID: 4622116

Source DB:  PubMed          Journal:  Ann Allergy        ISSN: 0003-4738


× No keyword cloud information.
  9 in total

1.  Neutralizing activity in the gastrointestinal contents of piglets vaccinated with an ethylenimine-inactivated porcine enterovirus.

Authors:  D G Hazlett; J B Derbyshire
Journal:  Can J Comp Med       Date:  1977-04

Review 2.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1973-05       Impact factor: 2.401

3.  The potential role of immunological adjuvants in influenza vaccines.

Authors:  D Hobson
Journal:  Postgrad Med J       Date:  1973-03       Impact factor: 2.401

4.  Immunity to influenza in ferrets. VI. Immunization with adjuvanted vaccines.

Authors:  C W Potter; R Jennings; C McLaren
Journal:  Arch Gesamte Virusforsch       Date:  1973

5.  The effect of adjuvants and prior immunization on the rate and mode of uptake of antigen into afferent popliteal lymph from sheep.

Authors:  K J Beh; A K Lascelles
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

6.  The effect of bacterial peptidoglycans on the immune response of hamsters to influenza virus vaccines.

Authors:  C R Crawford; R Jennings; N Bradford; C W Potter
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

7.  Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines.

Authors:  L Holten-Andersen; T M Doherty; K S Korsholm; P Andersen
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

8.  Immunity to influenza in ferrets. V. Immunization with inactivated virus in adjuvant 65.

Authors:  C W Potter; C McLaren; S L Shore
Journal:  J Hyg (Lond)       Date:  1973-03

9.  Adjuvant activity of a novel metabolizable lipid emulsion with inactivated viral vaccines.

Authors:  J A Reynolds; D G Harrington; C L Crabbs; C J Peters; N R Di Luzio
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.